`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`ELI LILLY AND COMPANY,
`Petitioner,
`
`v.
`
`TEVA PHARMACEUTICALS INTERNATIONAL GMBH,
`Patent Owner.
`
`_____________________
`
`Case IPR2018-01710 (Patent 8,586,045 B2)
`Case IPR2018-01711 (Patent 9,884,907 B2)
` Case IPR2018-01712 (Patent 9,884,908 B2)1
`_____________________
`
`TEVA PHARMACEUTICALS INTERNATIONAL
`GMBH’S UPDATED MANDATORY NOTICES
`
`
`
`
`
`
`
`
`
`
`1 This paper is filed in each proceeding identified in the caption.
`
`
`
`
`Patent Owner, Teva Pharmaceuticals International GmbH, hereby files
`
`IPR2018-01710 (Patent 8,586,045 B2)
`IPR2018-01711 (Patent 9,884,907 B2)
`IPR2018-01712 (Patent 9,884,908 B2)
`
`updated mandatory notices pursuant to 37 C.F.R. § 42.8(a)(3) in order to update
`
`counsel information.
`
`A. Lead and Backup Counsel (37 C.F.R. § 42.8(b)(3))
`
`Patent Owner designates the following lead and back-up counsel, adding
`
`additional counsel:
`
`Lead Counsel: Deborah A. Sterling (Reg. No. 62,732) phone: 202.772.8501
`Back-up Counsel: Robert C. Millonig (Reg. No. 34,395) phone: 202.371.2600
`
`
`
`Gaby L. Longsworth (Reg. No. 47,756) phone: 202.371.2600
`
`
`
`Jeremiah B. Frueauf (Reg. No. 66,638) phone: 202.371.2600
`
`
`
`Olga A. Partington (Reg. No. 65,326) phone: 202.371.2600
`
`
`
`Dennies Varughese (Reg. No. 61,868) phone: 202.371.2600
`
`Address:
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`1100 New York Avenue, NW
`Washington, DC 20005
`202.371.2600 (reception)
`202.371.2540 (facsimile)
`dsterling-PTAB@sternekessler.com
`bobm-PTAB@sternekessler.com
`glongs-PTAB@sternekessler.com
`jfrueauf-PTAB@sternekessler.com
`opartington-PTAB@sternekessler.com
`dvarughe-PTAB@sternekessler.com
`
`
`1
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2018-01710 (Patent 8,586,045 B2)
`IPR2018-01711 (Patent 9,884,907 B2)
`IPR2018-01712 (Patent 9,884,908 B2)
`Service Information (37 C.F.R. § 42.8(b)(4))
`
`B.
`
`Patent Owner consents to electronic service by email. Please direct all
`
`correspondence regarding this proceeding to the lead and back-up counsel at the
`
`addresses listed above.
`
`The Patent Trial and Appeal Board is hereby authorized to charge any fees
`
`associated with this proceeding to Deposit Account 19-0036 (Customer ID
`
`No. 45324).
`
` Respectfully Submitted,
` STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
`
`
` Deborah Sterling, Ph.D.
`Date: June 7, 2019
` Lead Attorney for Patent Owner
`
`
`
`
`
`1100 New York Avenue, N.W. Registration No. 62,732
`Washington, D.C. 20005-3934
`(202) 371-2600
`
`
`
`2
`
`
`
`CERTIFICATE OF SERVICE (37 C.F.R. § 42.6(e))
`
`
`
`The undersigned hereby certifies that the above-captioned “Teva
`
`Pharmaceuticals International GmbH’s Updated Mandatory Notices” was served in
`
`its entirety on June 7, 2019, upon the following via e-mail:
`
`Sanjay M. Jivraj
`Mark J. Stewart
`Eli Lilly and Company
`Lilly Corporate Center Patent Dept.
`Indianapolis, IN 46285
`jivraj_sanjay@lilly.com
`stewart_mark@lilly.com
`
`William B. Raich
`Erin M. Sommers
`Pier D. DeRoo
`Yieyie Yang
`Finnegan, Henderson, Farabow,
`Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001
`william.raich@finnegan.com
`erin.sommers@finnegan.com
`pier.deroo@finnegan.com
`yieyie.yang@finnegan.com
`
`
`
`
`
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
`
`
` Deborah Sterling, Ph.D.
`Date: June 7, 2019
` Lead Attorney for Patent Owner
`
`
`
`
`
`1100 New York Avenue, N.W. Registration No. 62,732
`Washington, D.C. 20005-3934
`(202) 371-2600
`13154766_1.DOC
`
`